Biotage offers solutions, knowledge and experience in the areas of analytical and organic chemistry. The customers include the world%u2019s top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com
Biotage announces the addition of ChemMatrix® resins to its extensive offering of peptide synthesis and purification products. ChemMatrix offers substantial advantages over traditional PS and PEG based resins for solid phase peptide synthesis.
Charlotte, North Carolina - Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, announced the add ...
Biotage announces the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen.
Uppsala, Sweden - Biotage (STO: BIOT), a leading supplier of tools and technology for medicinal and analytical chemistry, announced the second install ...